<?xml version="1.0" encoding="UTF-8"?> <rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" ><channel><title>Nurseslabs &#187; deficient fluid volume</title> <atom:link href="http://nurseslabs.com/tag/deficient-fluid-volume/feed/" rel="self" type="application/rss+xml" /><link>http://nurseslabs.com</link> <description></description> <lastBuildDate>Mon, 06 Feb 2012 07:07:27 +0000</lastBuildDate> <language>en</language> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <generator>http://wordpress.org/?v=3.3.1</generator> <xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /> <item><title>3 Placenta Previa Nursing Care Plans</title><link>http://nurseslabs.com/3-placenta-previa-nursing-care-plans/</link> <comments>http://nurseslabs.com/3-placenta-previa-nursing-care-plans/#comments</comments> <pubDate>Wed, 01 Feb 2012 11:00:55 +0000</pubDate> <dc:creator>NursesLabs</dc:creator> <category><![CDATA[Nursing Care Plans]]></category> <category><![CDATA[Decreased Cardiac Output]]></category> <category><![CDATA[deficient fluid volume]]></category> <category><![CDATA[ineffective tissue perfusion]]></category> <category><![CDATA[Pregnancy]]></category><guid isPermaLink="false">http://nurseslabs.com/?p=1253</guid> <description><![CDATA[<p>Placenta praevia (placenta previa AE) is an obstetric complication in which the placenta is attached to the uterine wall close to or covering the cervix. It can sometimes occur in the later part of the first trimester, but usually during the second or third. It is a leading cause of antepartum hemorrhage (vaginal bleeding). It [...]</p><p><a href="http://nurseslabs.com/3-placenta-previa-nursing-care-plans/">3 Placenta Previa Nursing Care Plans</a> Original source at: <a href="http://nurseslabs.com">Nurseslabs</a></p>]]></description> <content:encoded><![CDATA[<p><img class="alignright size-full wp-image-1525" style="margin: 8px;" title="Placenta Previa NCP" src="http://cdn.nurseslabs.com/wp-content/uploads/2010/09/Placenta-Previa-NCP.jpg" alt="" width="250" height="250" /></p><p style="text-align: left;"><strong>Placenta praevia (placenta previa AE)</strong> is an obstetric complication in which the placenta is attached to the uterine wall close to or covering the cervix. It can sometimes occur in the later part of the first trimester, but usually during the second or third. It is a leading cause of antepartum hemorrhage (vaginal bleeding). It affects approximately 0.5% of all labors.</p><p style="text-align: justify;">Read our Placenta Previa Nursing Care Plans below<br /></p><h2>1 Deficient Fluid Volume</h2><p style="text-align: justify;">Fluid volume deficit is a state in which an individual is experiencing decreased intravascular, interstitial and/or intracellular fluid. Active Blood Loss or Hemorrhage due to disrupted placental implantation during pregnancy may manifest signs and symptoms of fluid vol. deficient that may later lead to hypovolemic shock and cause maternal and fetal death.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td width="79"><strong>Assessment</strong></td><td width="66"><strong>Nursing Dx</strong></td><td width="84"><strong>Planning</strong></td><td width="102"><strong>Nursing</strong><strong> Inter­ventions</strong></td><td width="84"><strong>Rationale</strong></td><td width="72"><strong>Expected Outcome</strong></td></tr><tr><td valign="top" width="79">S-O-&gt;  Bleeding Episodes (amount, duration)</p><p>&gt; Facial Grimace due of Pain</p><p>&gt; Complaint of pain</p><p>Abdomen soft/hard when palpated</p><p>&gt; Manifest Body Weakness</p><p>&gt; Low BP</p><p>Increased HR</p><p>Decreased RR</p><p>Fetal HR &gt;120-160 bpm</p><p>&gt; Decreased Urine Out</p><p>&gt; Increased Urine Concentration</p><p>&gt; Pale, Cool Skin</p><p>&gt;Increased Capillary Refill</td><td valign="top" width="66">Deficient Fluid Volume r/t Active Blood Loss Secondary to Disrupted Placental Implantation</td><td valign="top" width="84">Short Term:After 4 hours of NI, the pt will verbalize understanding of causative factors.Long Term:</p><p>After 4 days of NI, the pt will maintain fluid volume at a functional level AEB individually adequate urinary output and stable vital signs.</td><td valign="top" width="102">1.     Establish Rapport2.     Monitor Vital Signs3.     Assess color, odor, consistency and amount of vaginal bleeding; weigh pads</p><p>4.     Assess hourly intake and output.</p><p>5.     Assess baseline data and note changes. Monitor FHR.</p><p>6.     Assess abdomen for tenderness or rigidity- if present, measure abdomen at umbilicus (specify time interval)</p><p>7.     Assess SaO2, skin color, temp, moisture, turgor, capillary refill (specify frequency)</p><p>8.     Assess for changes in LOC: note for complaints of thirst or apprehension</p><p>9.     Provide supplemental O2 as ordered via facemask or nasal cannula @ 10-12 L/min.</p><p>10.   Initiate IV fluids as ordered (specify fluid type and rate).</p><p>11.   Position Pt. in supine with hips elevated if ordered or left lateral position.</p><p>12.   Monitor lab. Work as obtained: Hgb &amp; Hct, Rh and type, cross match for 2 units RBCs, urinalysis, etc. Scheduled for ultrasound as ordered.</td><td valign="top" width="84">1.     To gain patient’s trust2.     To obtain baseline data3.     Provides information about active bleeding versus old blood, tissue loss and degree of blood loss</p><p>4.     Provides information about maternal and fetal physiologic compensation to blood loss</p><p>5.     Assessment provides information about possible infection, placenta previa or abruption. Warm, moist, bloody environment is ideal for growth of microorganisms.</p><p>6.     Detecting increased in measurement of abdominal girth suggests active abruption</p><p>7.     Assessment provides information about blood vol., O2 saturation and peripheral perfusion</p><p>8.     To detect signs of cerebral perfusion</p><p>9.     Intervention increases available O2 to saturate decreased hemoglobin</p><p>10.   For replacement of fluid vol. loss</p><p>11.   Position decreases pressure on placenta and cervical os. Left lateral position improves placental perfusion</p><p>12.   Lab. Work provides information about degree of blood loss; prepares for possible transfusion. Ultra sound provides info about the cause of bleeding</td><td valign="top" width="72">Short Term:The pt shall have verbalized understanding of causative factors.Long Term:</p><p>The pt shall have maintained fluid volume at a functional level AEB individually adequate urinary output and stable vital signs.</td></tr></tbody></table><h2></h2><h2><p><a href="http://nurseslabs.com/3-placenta-previa-nursing-care-plans/">3 Placenta Previa Nursing Care Plans</a> Original source at: <a href="http://nurseslabs.com">Nurseslabs</a></p>]]></content:encoded> <wfw:commentRss>http://nurseslabs.com/3-placenta-previa-nursing-care-plans/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>3 Diabetes Insipidus Nursing Care Plans</title><link>http://nurseslabs.com/diabetes-insipidus/</link> <comments>http://nurseslabs.com/diabetes-insipidus/#comments</comments> <pubDate>Tue, 24 Jan 2012 17:32:46 +0000</pubDate> <dc:creator>NursesLabs</dc:creator> <category><![CDATA[Nursing Care Plans]]></category> <category><![CDATA[deficient fluid volume]]></category> <category><![CDATA[deficient knowledge]]></category> <category><![CDATA[Diabetes Insipidus]]></category> <category><![CDATA[risk for impaired skin integrity]]></category><guid isPermaLink="false">http://nurseslabs.com/?p=639</guid> <description><![CDATA[<p>Diabetes Insipidus (DI) is a disorder in which there is an abnormal increase in urine output, fluid intake and often thirst.</p><p><a href="http://nurseslabs.com/diabetes-insipidus/">3 Diabetes Insipidus Nursing Care Plans</a> Original source at: <a href="http://nurseslabs.com">Nurseslabs</a></p>]]></description> <content:encoded><![CDATA[<p style="text-align: justify;"><img class="alignright size-full wp-image-4147" style="border-style: initial; border-color: initial; margin-top: 0px; margin-bottom: 0px; margin-left: 10px; margin-right: 10px; border-width: 0px;" title="NCP-Diabetes-Insipidus-Nursing-Care-Plans" src="http://cdn.nurseslabs.com/wp-content/uploads/2011/06/NCP-Diabetes-Insipidus-Nursing-Care-Plans.png" alt="" width="250" height="250" />Diabetes Insipidus (DI) is a disorder in which there is an abnormal increase in urine output, fluid intake and often thirst.</p><p style="text-align: justify;">It causes symptoms such as urinary frequency, nocturia (frequent awakening at night to urinate) or enuresis (involuntary urination during sleep or &#8220;bedwetting&#8221;).</p><p style="text-align: justify;">Urine output is increased because it is not concentrated normally.</p><p style="text-align: justify;">Consequently, instead of being a yellow color, the urine is pale, colorless or watery in appearance and the measured concentration (osmolality or specific gravity) is low (1).</p><p><img class="size-medium wp-image-640 aligncenter" style="border-style: initial; border-color: initial;" title="300px-Main_symptoms_of_diabetes" src="http://cdn.nurseslabs.com/wp-content/uploads/2010/04/300px-Main_symptoms_of_diabetes-271x300.png" alt="" width="271" height="300" /></p><h2>1. Deficient Fluid Volume</h2><div><table style="text-align: justify;" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td valign="top" width="295"><strong>Common Related Factors</strong></td><td valign="top" width="295"><strong>Defining Characteristics</strong></td></tr><tr><td valign="top" width="295">Compromised endocrine regulatory mechanismNeurohypophyseal dysfunctionHypopituitarismHypophysectomyNephrogenic DI</td><td valign="top" width="295">PolyuriaOutput exceeds intakePolydipsia (increased thirst)Sudden weight lossUrine specific gravity less than 1.005Urine osmolality less than 300 mOsm/LHypernatremia (sodium greater than 145 mEq/L)</p><p>Altered mental status</p><p>Requests for cold or ice water</td></tr><tr><td valign="top" width="295">Common Expected OutcomePatient experiences normal fluid volume as evidenced by absence of thirst, normal serum sodium level, and stable weight.</td><td valign="top" width="295"><strong>NOC Outcomes</strong>Fluid Balance; Electrolyte and Acid-Base Balance<strong>NIC Interventions</strong>Fluid Monitoring; Fluid Management; Electrolyte Management</td></tr></tbody></table><h3><strong>Ongoing Assessment</strong></h3><table style="text-align: justify;" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td valign="top" width="295">Actions/Interventions</td><td valign="top" width="295">Rationale</td></tr><tr><td valign="top" width="295">Monitor intake and output. Report urine volume greater than 200 mL for each of 2 consecutive hours or 500 mL in a 2-hour period.</td><td valign="top" width="295">With DI, the patient voids large urine volumes independent of the fluid intake. Urine output ranges from 2 to 3 L/day with renal DI to greater than 10 L/day with central DI.</td></tr><tr><td valign="top" width="295">Monitor for increased thirst (polydipsia).</td><td valign="top" width="295">If the patient is conscious and the thirst center is intact, thirst can be a reliable indicator of fluid balance. Polyuria and polydipsia strongly suggest DI. Also, the DI patient prefers ice water.</td></tr><tr><td valign="top" width="295">Weigh daily.</td><td valign="top" width="295">Weight loss occurs with excessive fluid loss.</td></tr><tr><td valign="top" width="295">Monitor urine specific gravity.</td><td valign="top" width="295">This may be 1.005 or less.</td></tr><tr><td valign="top" width="295">Monitor serum and urine osmolality.</td><td valign="top" width="295">Urine osmolality will be decreased and serum osmolality will increase.</td></tr><tr><td valign="top" width="295">Monitor urine and serum sodium levels.</td><td valign="top" width="295">The patient with DI has decreased urine sodium levels and hypernatremia.</td></tr><tr><td valign="top" width="295">Monitor serum potassium.</td><td valign="top" width="295">Hypokalemia may result from the increase in urinary output of potassium.</td></tr><tr><td valign="top" width="295">Monitor for signs of hypovolemic shock (e.g., tachycardia, tachypnea, hypotension).</td><td valign="top" width="295">Frequent assessment can detect changes early for rapid intervention. Polyuria causes decreased circulatory blood volume.</td></tr></tbody></table><h3 style="text-align: justify;"><span style="line-height: 23px; font-size: 21px;"><strong>Therapeutic Interventions</strong></span></h3><table style="text-align: justify;" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td valign="top" width="295">Actions/Interventions</td><td valign="top" width="295">Rationale</td></tr><tr><td valign="top" width="295">Allow the patient to drink water at will.</td><td valign="top" width="295">Patients with intact thirst mechanisms may maintain fluid balance by drinking huge quantities of water to compensate for the amount they urinate. Patients prefer cold or ice water.</td></tr><tr><td valign="top" width="295">Provide easily accessible fluid source, keeping adequate fluids at bedside.</td><td valign="top" width="295">This encourages fluid intake.</td></tr><tr><td valign="top" width="295">Administer intravenous (IV) fluids:</td><td valign="top" width="295">IV fluids are indicated if the patient cannot take in sufficient fluids orally.</td></tr><tr><td valign="top" width="295"><ul><li>5% dextrose in water or 0.45% sodium chloride</li></ul></td><td valign="top" width="295">Hypotonic IV fluids provide free water and help lower serum sodium levels gradually.</td></tr><tr><td valign="top" width="295"><ul><li>0.9% sodium chloride</li></ul></td><td valign="top" width="295">Isotonic fluids may be indicated for the patient who has sustained significant fluid loss and is hemodynamically unstable. Once circulatory volume has been restored, hypotonic IV fluids can be given.</td></tr><tr><td valign="top" width="295">Administer medication as prescribed.</td><td valign="top" width="295">Aqueous vasopressin is usually used for DI of short duration (e.g., postoperative neurosurgery or head trauma). Pitressin tannate (vasopressin) in oil (the longer-acting vasopressin) is used for longer-term DI. Patients with milder forms of DI may use chlorpropamide (Diabinese), clofibrate (Atromid), or carbamazepine (Tegretol) to stimulate release of ADH from the posterior pituitary and enhance its action on the renal tubules. Hydrochlorothiazide (HydroDIURIL) may also be used for nephrogenic DI.</td></tr><tr><td valign="top" width="295">If vasopressin is given, monitor for water intoxication or rebound hyponatremia.</td><td valign="top" width="295">Overmedication can result in volume excess.</td></tr></tbody></table><h2 style="text-align: justify;"><span style="line-height: 28px; font-size: 26px;"><strong>2. Risk for Impaired Skin Integrity</strong></span></h2><table style="text-align: justify;" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td valign="top" width="295">Common Risk Factor</td><td valign="top" width="295"></td></tr><tr><td valign="top" width="295">Urinary frequency with high volume output and the potential for incontinence</td><td valign="top" width="295"></td></tr><tr><td valign="top" width="295">Common Expected OutcomePatient’s skin remains intact.</td><td valign="top" width="295"><strong>NOC Outcomes</strong>Tissue Integrity: Skin and Mucous Membranes; Risk Control; Risk Detection<strong>NIC Interventions</strong>Skin Surveillance; Skin Care: Topical Treatments</td></tr></tbody></table><h3><strong>Ongoing Assessment</strong></h3><table style="text-align: justify;" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td valign="top" width="295">Actions/Interventions</td><td valign="top" width="295">Rationale</td></tr><tr><td valign="top" width="295">Inspect skin; document condition and changes in status.</td><td valign="top" width="295">Early detection and intervention may prevent occurrence or progression of impaired skin integrity. Fluid loss from polyuria contributes to decreased skin turgor and dryness.</td></tr><tr><td valign="top" width="295">Assess for continence or incontinence. Evaluate need for an indwelling urinary catheter.</td><td valign="top" width="295">Excessive moisture on the skin increases the risk of skin breakdown.</td></tr><tr><td valign="top" width="295">Assess other factors that may risk the patient’s skin integrity (e.g., immobility, nutritional status, altered mental status).</td><td valign="top" width="295">Excessive moisture from urinary incontinence can add to the risk for skin breakdown from other sources.</td></tr></tbody></table><h3><strong>Therapeutic Interventions</strong></h3><table style="text-align: justify;" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td valign="top" width="295">Actions/Interventions</td><td valign="top" width="295">Rationale</td></tr><tr><td valign="top" width="295">Provide easy access to the bathroom, urinal, or bedpan.</td><td valign="top" width="295">Both polyuria and polydipsia disrupt the patient’s normal activities (including sleep). Easy access to void will decrease inconvenience and frustration.</td></tr><tr><td valign="top" width="295">Use skin barriers as needed.</td><td valign="top" width="295">These prevent redness or excoriation from urinary frequency.</td></tr><tr><td valign="top" width="295">Keep bed linen clean, dry, and wrinkle-free.</td><td valign="top" width="295">This prevents shearing forces.</td></tr></tbody></table><h2><strong>3. Deficient Knowledge</strong></h2><table style="text-align: justify;" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td valign="top" width="295">Common Related Factors</td><td valign="top" width="295">Defining Characteristics</td></tr><tr><td valign="top" width="295">New conditionUnfamiliarity with disease and treatment</td><td valign="top" width="295">QuestionsRequests for more informationVerbalized misconceptions or misinterpretation</td></tr><tr><td valign="top" width="295">Common Expected OutcomePatient verbalizes correct understanding of DI and the medications used in treatment.</td><td valign="top" width="295"><strong>NOC Outcomes</strong>Knowledge: Disease Process; Knowledge: Medication<strong>NIC Interventions</strong>Teaching: Disease Process; Teaching: Prescribed Medication</td></tr></tbody></table><h3><strong>Ongoing Assessment</strong></h3><table style="text-align: justify;" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td valign="top" width="295">Actions/Interventions</td><td valign="top" width="295">Rationale</td></tr><tr><td valign="top" width="295">Assess level of knowledge of DI cause and treatment.</td><td valign="top" width="295">An individualized teaching plan is based on the patient’s current knowledge and desire for additional information.</td></tr><tr><td valign="top" width="295">Assess readiness to learn.</td><td valign="top" width="295">Rapid fluid loss from polyuria can lead to impaired cognitive function. This change in mental status can limit the patient’s ability to learn new information.</td></tr></tbody></table><h3><strong>Therapeutic Interventions</strong></h3><table style="text-align: justify;" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td valign="top" width="295"><strong>Actions/Interventions</strong></td><td valign="top" width="295"><strong>Rationale</strong></td></tr><tr><td valign="top" width="295">Give written information concerning the diagnosis and treatment of DI:</td><td valign="top" width="295"></td></tr><tr><td valign="top" width="295"><ul><li>Water deprivation ADH stimulation test</li></ul></td><td valign="top" width="295">This test may be done to differentiate nephrogenic causes from neurogenic causes of DI. The patient is instructed to take nothing by mouth (NPO) for 12 hours before a blood sample is drawn to measure ADH levels. The ADH level is increased in nephrogenic DI and decreased in neurogenic (central) DI. Vasopressin may be given to evaluate renal response. There is no response to the drug in nephrogenic DI.</td></tr><tr><td valign="top" width="295"><ul><li>Computed tomography scan or magnetic resonance imaging</li></ul></td><td valign="top" width="295">These scans may be ordered if a pituitary tumor is suspected.</td></tr><tr><td valign="top" width="295"><ul><li>Desmopressin acetate (DDAVP)</li></ul></td><td valign="top" width="295">This is the drug of choice for the management of DI. This medication is a synthetic form of ADH and is administered intranasally.</td></tr><tr><td valign="top" width="295"><ul><li>Aqueous form of ADH (vasopressin)</li></ul></td><td valign="top" width="295">This drug has a shorter half-life than DDAVP and therefore requires more frequent daily administration. Vasopressin is usually given parenterally and is not recommended for the long-term management of chronic DI.</td></tr><tr><td valign="top" width="295"><ul><li>Other drugs used in combination to manage DI, including chlorpropamide (Diabinese), clofibrate (Atromid), carbamazepine (Tegretol), and hydrochlorothiazide</li></ul></td><td valign="top" width="295">These secondary drugs work on the kidney or the posterior pituitary gland to increase pituitary release of ADH or increase renal response to ADH.</td></tr><tr><td valign="top" width="295">Teach the patient the necessity of closely monitoring fluid balance, including daily weights (same time of day with same amount of clothing), fluid intake and output, and measurement of urine specific gravity.</td><td valign="top" width="295">This assists the patient in monitoring the condition so that adjustments can be made accordingly, helping prevent undertreatment or overtreatment with the medication,.</td></tr><tr><td valign="top" width="295">Discuss when to seek further medical attention (at signs of underdosage or overdosage of medications).</td><td valign="top" width="295">Patients with chronic disease need to be able to recognize important changes in their condition to avert complications and possible hospitalization.</td></tr><tr><td valign="top" width="295">Instruct the patient to wear a medical alert bracelet, listing DI and the medications that the patient is using.</td><td valign="top" width="295">This allows for prompt intervention in the event of an emergency.</td></tr></tbody></table><p style="text-align: justify;"><strong>Sources:</strong> (<a href="http://nursingcareplan.blogspot.com/search?updated-max=2009-09-30T08:41:00%2B08:00&amp;max-results=1">1</a>) (<a href="http://images.google.com/imgres?imgurl=http://upload.wikimedia.org/wikipedia/commons/thumb/2/28/Main_symptoms_of_diabetes.png/300px-Main_symptoms_of_diabetes.png&amp;imgrefurl=http://www.socialsecurityhome.com/disabilityblog/2010/03/19/diabetes-insipidus-and-receiving-social-security-disability/&amp;usg=__hc6nlFR-ESj_4u_5K-OkMtnzqpg=&amp;h=332&amp;w=300&amp;sz=92&amp;hl=en&amp;start=108&amp;um=1&amp;itbs=1&amp;tbnid=BU1u7ZjtjE5-AM:&amp;tbnh=119&amp;tbnw=108&amp;prev=/images%3Fq%3Ddiabetes%2Binsipidus%26start%3D100%26um%3D1%26hl%3Den%26sa%3DN%26ndsp%3D20%26tbs%3Disch:1">2</a>)</p></div><p><a href="http://nurseslabs.com/diabetes-insipidus/">3 Diabetes Insipidus Nursing Care Plans</a> Original source at: <a href="http://nurseslabs.com">Nurseslabs</a></p>]]></content:encoded> <wfw:commentRss>http://nurseslabs.com/diabetes-insipidus/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Deficient Knowledge &#124; Diabetes Insipidus Nursing Care Plans</title><link>http://nurseslabs.com/deficient-knowledge-diabetes-insipidus-nursing-care-plans/</link> <comments>http://nurseslabs.com/deficient-knowledge-diabetes-insipidus-nursing-care-plans/#comments</comments> <pubDate>Thu, 12 Jan 2012 14:49:27 +0000</pubDate> <dc:creator>NursesLabs</dc:creator> <category><![CDATA[Nursing Care Plans]]></category> <category><![CDATA[assessment]]></category> <category><![CDATA[deficient fluid volume]]></category> <category><![CDATA[deficient knowledge]]></category> <category><![CDATA[Diabetes Insipidus]]></category> <category><![CDATA[Diabetes Insipidus Interventions]]></category> <category><![CDATA[Diabetes Polyuria Management]]></category> <category><![CDATA[nursing care plans]]></category> <category><![CDATA[Nursing Care Plans DI]]></category> <category><![CDATA[nursing diagnosis]]></category> <category><![CDATA[risk for impaired skin integrity]]></category><guid isPermaLink="false">http://nurseslabs.com/?p=2261</guid> <description><![CDATA[<p>Common Related Factors New condition Unfamiliarity with disease and treatment Defining Characteristics Questions Requests for more information Verbalized misconceptions or misinterpretation Common Expected Outcomes Patient verbalizes correct understanding of DI and the medications used in treatment. NOC Outcomes Knowledge: Disease Process; Knowledge: Medication NIC Interventions Teaching: Disease Process; Teaching: Prescribed Medication Ongoing Assessment Assess level [...]</p><p><a href="http://nurseslabs.com/deficient-knowledge-diabetes-insipidus-nursing-care-plans/">Deficient Knowledge | Diabetes Insipidus Nursing Care Plans</a> Original source at: <a href="http://nurseslabs.com">Nurseslabs</a></p>]]></description> <content:encoded><![CDATA[<h2><a href="http://cdn.nurseslabs.com/wp-content/uploads/2011/05/NCP-DI-Deficient-Knowledge.jpg"><img class="alignright size-full wp-image-2262" title="NCP-DI Deficient Knowledge" src="http://cdn.nurseslabs.com/wp-content/uploads/2011/05/NCP-DI-Deficient-Knowledge.jpg" alt="NCP-DI Deficient Knowledge" width="250" height="250" /></a>Common Related Factors</h2><ul><li>New condition</li><li>Unfamiliarity with   disease and treatment</li></ul><h2>Defining Characteristics</h2><ul><li>Questions</li><li>Requests for more   information</li><li>Verbalized   misconceptions or misinterpretation</li></ul><h2>Common Expected Outcomes</h2><ul><li>Patient verbalizes   correct understanding of DI and the medications used in treatment.</li></ul><div><strong>NOC Outcomes</strong></div><div><ul><li>Knowledge: Disease Process;</li><li>Knowledge: Medication</li></ul></div><div><strong>NIC Interventions</strong></div><ul><li>Teaching: Disease Process;</li><li>Teaching: Prescribed Medication</li></ul><h2>Ongoing Assessment</h2><ol><li>Assess level of knowledge of DI cause   and treatment. <em>An individualized   teaching plan is based on the patient’s current knowledge and desire for   additional information.</em></li><li>Assess readiness to learn.<em> Rapid fluid loss from   polyuria can  lead to impaired cognitive function. This change in mental   status can  limit the patient’s ability to learn new information.</em></li></ol><h2>Nursing Interventions</h2><ol><li style="text-align: justify;">Give written information concerning the   diagnosis and treatment of DI:<ul style="text-align: justify;"><li><strong>Water deprivation ADH stimulation test</strong><ul><li>This test may be done   to  differentiate nephrogenic causes from neurogenic causes of DI. The  patient   is instructed to take nothing by mouth (NPO) for 12 hours  before a blood   sample is drawn to measure ADH levels. The ADH level is  increased in   nephrogenic DI and decreased in neurogenic (central) DI.  Vasopressin may be   given to evaluate renal response. There is no  response to the drug in   nephrogenic DI.</li></ul></li><li><strong>Computed tomography scan or magnetic resonance   imaging</strong><ul><li>These scans may be   ordered if a pituitary tumor is suspected.</li></ul></li><li><strong>Desmopressin acetate (DDAVP)</strong><ul><li>This is the drug of choice   for the  management of DI. This medication is a synthetic form of ADH and is    administered intranasally.</li></ul></li><li><strong>Aqueous form of ADH (vasopressin)</strong><ul><li>This drug has a   shorter half-life  than DDAVP and therefore requires more frequent daily   administration.  Vasopressin is usually given parenterally and is not   recommended for  the long-term management of chronic DI.</li></ul></li><li><strong>Other drugs used in combination to  manage DI,   including chlorpropamide (Diabinese), clofibrate (Atromid),  carbamazepine   (Tegretol), and hydrochlorothiazide</strong><ul><li>These secondary drugs   work on the  kidney or the posterior pituitary gland to increase pituitary   release  of ADH or increase renal response to ADH.</li></ul></li></ul></li></ol><ol><li style="text-align: justify;">Teach the patient the necessity of    closely monitoring fluid balance, including daily weights (same time of  day   with same amount of clothing), fluid intake and output, and  measurement of   urine specific gravity. <em>This assists the   patient in  monitoring the condition so that adjustments can be made   accordingly,  helping prevent undertreatment or overtreatment with the   medication.</em></li><li style="text-align: justify;">Discuss when to seek further medical   attention (at signs of underdosage or overdosage of medications).  <em>Patients with chronic   disease need to  be able to recognize important changes in their condition to   avert  complications and possible hospitalization.</em></li><li style="text-align: justify;">Instruct the patient to wear a medical   alert bracelet, listing DI and the medications that the patient is using.  <em>This allows for prompt   intervention in the event of an emergency.</em></li></ol><p><a href="http://nurseslabs.com/deficient-knowledge-diabetes-insipidus-nursing-care-plans/">Deficient Knowledge | Diabetes Insipidus Nursing Care Plans</a> Original source at: <a href="http://nurseslabs.com">Nurseslabs</a></p>]]></content:encoded> <wfw:commentRss>http://nurseslabs.com/deficient-knowledge-diabetes-insipidus-nursing-care-plans/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>4 Diabetes Mellitus Nursing Care Plans</title><link>http://nurseslabs.com/4-diabetes-mellitus-nursing-care-plans/</link> <comments>http://nurseslabs.com/4-diabetes-mellitus-nursing-care-plans/#comments</comments> <pubDate>Fri, 06 Jan 2012 23:00:18 +0000</pubDate> <dc:creator>NursesLabs</dc:creator> <category><![CDATA[Nursing Care Plans]]></category> <category><![CDATA[activity intolerance]]></category> <category><![CDATA[deficient fluid volume]]></category> <category><![CDATA[fatigue]]></category> <category><![CDATA[risk for infection]]></category><guid isPermaLink="false">http://nurseslabs.com/?p=737</guid> <description><![CDATA[<p>Diabetes mellitus is a metabolic disease characterized by dysregulation of carbohydrate, protein, and lipid metabolism. Here you view 4 Diabetes Mellitus Nursing Care Plans</p><p><a href="http://nurseslabs.com/4-diabetes-mellitus-nursing-care-plans/">4 Diabetes Mellitus Nursing Care Plans</a> Original source at: <a href="http://nurseslabs.com">Nurseslabs</a></p>]]></description> <content:encoded><![CDATA[<p style="text-align: justify;"><img class="alignright size-full wp-image-1680" style="border-style: initial; border-color: initial; border-width: 0px; margin: 10px;" title="Diabetes Mellitus Nursing Care Plans" src="http://cdn.nurseslabs.com/wp-content/uploads/2010/05/DM-NCPs.jpg" alt="Diabetes Mellitus Nursing Care Plans" width="250" height="250" /><strong>Diabetes mellitus</strong> is a metabolic disease characterized by dysregulation of carbohydrate, protein, and lipid metabolism. The primary feature of this disorder is elevation in blood glucose levels (hyperglycemia), resulting from either a defect in insulin secretion from the pancreas, a change in insulin action, or both. Sustained hyperglycemia has been shown to affect almost all tissues in the body and is associated with significant complications of multiple organ systems, including the eyes, nerves, kidneys, and blood vessels.</p><p style="text-align: justify;">Here you view 4 Diabetes Mellitus Nursing Care Plans</p><p></p><h2>1. Deficient Fluid Volume</h2><p style="text-align: justify;">Glucose appears in the urine (glycosuria) because the kidney excretes the excess glucose to make the blood glucose level normal. Glucose excreted in the urine acts as osmotic diuretic and causes excretion of increased amount of water, resulting in fluid volume deficit or polyuria.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td valign="top" width="76"><strong>Assessment</strong></td><td valign="top" width="69"><strong>Nursing Diagnosis</strong></td><td valign="top" width="123"><strong>Planning</strong></td><td valign="top" width="112"><strong>Nursing<br /> Interventions</strong></td><td valign="top" width="100"><strong>Rationale</strong></td><td valign="top" width="102"><strong>Evaluation</strong></td></tr><tr><td valign="top" width="76"><strong>Subjective:</strong>(none)<strong>Objective:</strong></p><ul><li>elevated     temperature of 38.4°C/axilla</li><li>increased urine output.</li><li>sweating of the skin</li><li>thirst</li><li>exhaustion</li><li>weight loss</li><li>dry skin or  mucous membrane</li></ul></td><td valign="top" width="69">Deficient Fluid Volume r/t intracellular DHN 2° the DM II</td><td valign="top" width="123"><span style="text-decoration: underline;"><strong>Short Term</strong></span><strong>:</strong>After 3° of NI, patient shall have verbalized understanding of causative factors and purpose of individual therapeutic interventions and medications.<span style="text-decoration: underline;"><strong>Long Term</strong></span><strong>:</strong>After 2 days of NI, the patient shall have maintained fluid volume at a functional level as evidenced by individual good skin turgor, moist mucous membrane and stable vital signs.</td><td valign="top" width="112">Establish rapportTake and record vital signsMonitor the temperatureAssess skin turgor and mucous membranes for signs of dehydrationEncourage the patient to increase fluid intake</p><p>Administer IVF as ordered by the Doctor</p><p>Administer anti-pyretic as prescribed by the Doctor.</td><td valign="top" width="100">Friendly relationship with patient and to be able to each other’s concernTo obtain baseline dataTo monitor changes in temperatureDry skin and mucous membranes are signs of dehydrationTo replace fluid loss and prevent dehydration</p><p>To replace electrolytes and fluid loss</p><p>To decrease body temperature and will have less occurrence of dehydration.</td><td valign="top" width="102"><span style="text-decoration: underline;"><strong>Short Term</strong></span><strong>:</strong>After 3° of NI, patient will have verbalized understanding of causative factors and purpose of individual therapeutic interventions and medications.<span style="text-decoration: underline;"><strong>Long Term</strong></span><strong>:</strong>After 2 days of NI, the patient will have maintained fluid volume at a functional level as evidenced by individual good skin turgor, moist mucous membrane and stable vital signs</td></tr></tbody></table><p><a href="http://nurseslabs.com/4-diabetes-mellitus-nursing-care-plans/">4 Diabetes Mellitus Nursing Care Plans</a> Original source at: <a href="http://nurseslabs.com">Nurseslabs</a></p>]]></content:encoded> <wfw:commentRss>http://nurseslabs.com/4-diabetes-mellitus-nursing-care-plans/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Deficient Fluid Volume &#124; Diabetes Insipidus Nursing Care Plans</title><link>http://nurseslabs.com/deficient-fluid-volume-diabetes-insipidus-nursing-care-plans/</link> <comments>http://nurseslabs.com/deficient-fluid-volume-diabetes-insipidus-nursing-care-plans/#comments</comments> <pubDate>Fri, 16 Dec 2011 02:18:40 +0000</pubDate> <dc:creator>NursesLabs</dc:creator> <category><![CDATA[Nursing Care Plans]]></category> <category><![CDATA[assessment]]></category> <category><![CDATA[deficient fluid volume]]></category> <category><![CDATA[Diabetes Insipidus Interventions]]></category> <category><![CDATA[Diabetes Polyuria Management]]></category> <category><![CDATA[nursing care plans]]></category> <category><![CDATA[nursing diagnosis]]></category> <category><![CDATA[Urinary System]]></category><guid isPermaLink="false">http://nurseslabs.com/?p=2253</guid> <description><![CDATA[<p>Diabetes Insipidus Interventions, Assessment, Deficient Fluid Volume, Nursing Care Plans</p><p><a href="http://nurseslabs.com/deficient-fluid-volume-diabetes-insipidus-nursing-care-plans/">Deficient Fluid Volume | Diabetes Insipidus Nursing Care Plans</a> Original source at: <a href="http://nurseslabs.com">Nurseslabs</a></p>]]></description> <content:encoded><![CDATA[<h2><a href="http://cdn.nurseslabs.com/wp-content/uploads/2011/05/NCP-DI-Deficient-Fluid-Volume.jpg"><img class="alignright size-full wp-image-2254" title="NCP-DI Deficient Fluid Volume" src="http://cdn.nurseslabs.com/wp-content/uploads/2011/05/NCP-DI-Deficient-Fluid-Volume.jpg" alt="NCP-DI Deficient Fluid Volume" width="250" height="250" /></a>Common Related Factors</h2><ul><li>Compromised endocrine   regulatory mechanism</li><li>Neurohypophyseal   dysfunction</li><li>Hypopituitarism</li><li>Hypophysectomy</li><li>Nephrogenic DI</li></ul><h2>Defining Characteristics</h2><ul><li>Polyuria</li><li>Output exceeds intake</li><li>Polydipsia (increased   thirst)</li><li>Sudden weight loss</li><li>Urine specific gravity   less than 1.005</li><li>Urine osmolality less   than 300 mOsm/L</li><li>Hypernatremia (sodium   greater than 145 mEq/L)</li><li>Altered mental status</li><li>Requests for cold or   ice water</li></ul><h2>Common Expected Outcomes</h2><ul><li>Patient experiences   normal fluid volume as evidenced by absence of thirst, normal serum sodium   level, and stable weight.</li></ul><h3><strong>NOC Outcomes</strong></h3><div><ul><li>Fluid Balance; Electrolyte and Acid-Base Balance</li></ul></div><h3><strong>NIC Interventions</strong></h3><ul><li>Fluid Monitoring; Fluid Management; Electrolyte Management</li></ul><h2>Ongoing Assessment</h2><ol><li>Monitor intake and output. Report    urine volume greater than 200 mL for each of 2 consecutive hours or 500  mL in   a 2-hour period. <em>With DI, the patient   voids large  urine volumes independent of the fluid intake. Urine output   ranges  from 2 to 3 L/day with renal DI to greater than 10 L/day with central    DI.</em></li><li>Monitor for increased thirst   (polydipsia).<em> If the patient is   conscious and the  thirst center is intact, thirst can be a reliable indicator   of fluid  balance. Polyuria and polydipsia strongly suggest DI. Also, the DI    patient prefers ice water.</em></li><li>Weigh daily. <em>Weight loss occurs   with excessive fluid loss.</em></li><li>Monitor urine specific gravity. <em>This may be 1.005 or   less.</em></li><li>Monitor serum and urine osmolality. <em>Urine osmolality will   be decreased and serum osmolality will increase.</em></li><li>Monitor urine and serum sodium levels. <em>The patient with DI   has decreased urine sodium levels and hypernatremia.</em></li><li>Monitor serum potassium.<em> Hypokalemia may result   from the increase in urinary output of potassium.</em></li><li>Monitor for signs of hypovolemic shock   (e.g., tachycardia, tachypnea, hypotension). <em>Frequent assessment   can detect changes early for rapid intervention. Polyuria causes decreased   circulatory blood volume.</em></li></ol><h2>Nursing Interventions</h2><ol><li>Allow the patient to drink water at   will. <em>Patients with intact   thirst  mechanisms may maintain fluid balance by drinking huge quantities of    water to compensate for the amount they urinate. Patients prefer cold or  ice   water.</em></li><li>Provide easily accessible fluid   source, keeping adequate fluids at bedside. <em>This encourages fluid   intake.</em></li><li>Administer intravenous (IV) fluids:<em> IV fluids are   indicated if the patient cannot take in sufficient fluids orally.</em></li></ol><blockquote><ul><li>5% dextrose in water or 0.45% sodium chloride.<em> Hypotonic IV fluids   provide free water and help lower serum sodium levels gradually.</em></li><li>0.9% sodium chloride. <em>Isotonic fluids may be   indicated for  the patient who has sustained significant fluid loss and is    hemodynamically unstable. Once circulatory volume has been restored,    hypotonic IV fluids can be given.</em></li></ul></blockquote><ol><li>Administer medication as prescribed.  <em>Aqueous vasopressin is   usually used  for DI of short duration (e.g., postoperative neurosurgery or   head  trauma). Pitressin tannate (vasopressin) in oil (the longer-acting    vasopressin) is used for longer-term DI. Patients with milder forms of  DI may   use chlorpropamide (Diabinese), clofibrate (Atromid), or  carbamazepine   (Tegretol) to stimulate release of ADH from the  posterior pituitary and   enhance its action on the renal tubules.  Hydrochlorothiazide (HydroDIURIL)   may also be used for nephrogenic DI.</em></li><li>If vasopressin is given, monitor for   water intoxication or rebound hyponatremia. <em>Overmedication can   result in volume excess.</em></li></ol><p><a href="http://nurseslabs.com/deficient-fluid-volume-diabetes-insipidus-nursing-care-plans/">Deficient Fluid Volume | Diabetes Insipidus Nursing Care Plans</a> Original source at: <a href="http://nurseslabs.com">Nurseslabs</a></p>]]></content:encoded> <wfw:commentRss>http://nurseslabs.com/deficient-fluid-volume-diabetes-insipidus-nursing-care-plans/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>7 Gastroenteritis Nursing Care Plans</title><link>http://nurseslabs.com/gastroenteritis-nursing-care-plans/</link> <comments>http://nurseslabs.com/gastroenteritis-nursing-care-plans/#comments</comments> <pubDate>Fri, 04 Nov 2011 12:00:28 +0000</pubDate> <dc:creator>NursesLabs</dc:creator> <category><![CDATA[Nursing Care Plans]]></category> <category><![CDATA[activity intolerance]]></category> <category><![CDATA[acute pain]]></category> <category><![CDATA[deficient fluid volume]]></category><guid isPermaLink="false">http://nurseslabs.com/?p=195</guid> <description><![CDATA[<p>Gastroenteritis is an inflammation of the stomach and intestinal tract that primarily affects the small bowel. The major clinical manifestations are diarrhea of varying degrees and abdominal pain and cramping. Associated clinical manifestations are nausea, vomiting, fever anorexia, distention, tenesmus, and borborygmi.</p><p><a href="http://nurseslabs.com/gastroenteritis-nursing-care-plans/">7 Gastroenteritis Nursing Care Plans</a> Original source at: <a href="http://nurseslabs.com">Nurseslabs</a></p>]]></description> <content:encoded><![CDATA[<p style="text-align: justify;"><strong><a href="http://cdn.nurseslabs.com/wp-content/uploads/2010/01/Gastroenteritis1.jpg"><img class="alignright size-full wp-image-1591" style="margin: 8px;" title="Gastroenteritis" src="http://cdn.nurseslabs.com/wp-content/uploads/2010/01/Gastroenteritis1.jpg" alt="" width="250" height="250" /></a><a title="activity intolerance, acute pain, deficient fluid volume, diarrhea, digestive nursing care plan for acute gastroenteritis, acute gastroenteritis ncp, acute gastroenteritis with some dehydration, nursing diagnosis for gastroenteritis, nursing care plan for gastroenteritis, gastroenteritis nursing care plan, acute gastroenteritis nursing care plan, gastroenteritis nursing diagnosis, ncp for acute gastroenteritis with some dehydration, acute gastroenteritis nursing intervention" href="http://nurseslabs.com/nursing-care-plans/gastroenteritis-nursing-care-plans/">Gastroenteritis</a></strong> is an inflammation of the stomach and intestinal tract that primarily affects the small bowel.</p><p style="text-align: justify;">The major clinical manifestations are diarrhea of varying degrees and abdominal pain and cramping. Associated clinical manifestations are nausea, vomiting, fever anorexia, distention, tenesmus, and borborygmi.</p><p style="text-align: justify;">The nursing goals for patients with Acute Gastroenteritis are toward: avoiding dehydration and management of diarrhea. This post contains 4 nursing care plans.</p><p><span id="more-195"></span></p><p></p><h2>1. Diarrhea</h2><p style="text-align: justify;">Diarrhea is defined as an increase in the frequency, volume and fluid content of stool. Rapid propulsion of intestinal contents through the small bowel results in diarrhea. Diarrhea is a hallmark sign of gastroenteritis.</p><object id="_ds_71181794" name="_ds_71181794" width="630" height="550"  type="application/x-shockwave-flash" data="http://viewer.docstoc.com/"><param name="FlashVars" value="doc_id=71181794&mem_id=6689522&doc_type=ppt&fullscreen=0&allowdownload=1&showrelated=1&showotherdocs=1" /><param name="movie" value="http://viewer.docstoc.com/"/><param name="allowScriptAccess" value="always" /><param name="allowFullScreen" value="true" /> </object> <br/><script type="text/javascript">var docstoc_docid="71181794";var docstoc_title="Diarrhea- AGE";var docstoc_urltitle="Diarrhea- AGE";</script><script type="text/javascript" src="http://i.docstoccdn.com/js/check-flash.js"></script><a style="font-size:0.75em" href="http://www.docstoc.com/docs/71181794/Diarrhea--AGE" target="_blank">Diarrhea- AGE</a><p><a href="http://nurseslabs.com/gastroenteritis-nursing-care-plans/">7 Gastroenteritis Nursing Care Plans</a> Original source at: <a href="http://nurseslabs.com">Nurseslabs</a></p>]]></content:encoded> <wfw:commentRss>http://nurseslabs.com/gastroenteritis-nursing-care-plans/feed/</wfw:commentRss> <slash:comments>2</slash:comments> </item> </channel> </rss>
<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk: basic
Page Caching using disk: basic
Database Caching 63/131 queries in 5.186 seconds using disk: basic
Object Caching 3894/3974 objects using disk: basic
Content Delivery Network via cdn.nurseslabs.com

Served from: nurseslabs.com @ 2012-02-06 21:39:12 -->
